Advertisement
Advertisement
AUPH
Aurinia Pharmaceuticals Inc
8.15
USD-0.03
-0.42%
Mar 07, 15:59 UTC -5
Closed
After-Market
8.155
0
+0.06%
Aurinia Pharmaceuticals Inc Profile
About
Info & Links
CEO
Peter Greenleaf
Headquarters
EDMONTON, A0 T5L 4S6, CANADA
Industry
Sector
Website
Auditor
PricewaterhouseCoopers LLP
Share holders
110
Employees
300
Aurinia Pharmaceuticals Inc Statistics
Valuation Measures
Market Capitalization2
1.12B
Enterprise Value
1.16B
Enterprise Value/EBITDA(ttm)
-296.34
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
5.09
Price to Book(mrq)
2.89
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
87.71%
Operating Margin(ttm)
-7.45%
Profit Margin(ttm)
0.86%
Return on Equity(ttm)
-4.41%
Return on Invested Capital(ttm)
1.14%
Return on Assets(ttm)
-3.07%
Income Statement
Revenue(ttm)
220.36M
Revenue Per Share(ttm)
1.54
Gross Profit(ttm)
192.27M
EBITDA(ttm)3
-3.93M
Net Income Available to Common(ttm)
-22.55M
Diluted EPS(ttm)
-0.15
Share Statistics
Beta (5Y Monthly)
1.22
52-Week Change
49.54%
S&P 500 52-Week Change
12.74%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
143.18M
Dividend Yield
0.00%
Float4
137.02M
% Held by Insiders
4.30%
% Held by Institutions
36.83%
Balance Sheet
Total Cash(mrq)
348.75M
Total Cash Per Share(mrq)
2.44
Total Debt(mrq)
80.88M
Total Debt/Equity(mrq)
19.23%
Current Ratio(mrq)
4.57%
Quick Ratio(mrq)
5.11%
Book Value Per Share(mrq)
2.68
Cash Flow
Operating Cash Flow Per Share(ytd)
0.30
Free Cash Flow(ytd)
44.11M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement